Phase II Trial of Busulfan-Based Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed By Reduced Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma

Saved in:
Bibliographic Details
Published in:Biology of blood and marrow transplantation 2014-02, Vol.20 (2), p.S73-S73
Main Authors: Chen, Yi-Bin, MD, Li, Shuli, Del Rio, Candice, RN, Driscoll, Jessica, NP, Sadrzadeh, Hossein, Abramson, Jeremy S, Armand, Philippe, MD, PhD, Barnes, Jeffrey, Cutler, Corey S., MD, Fisher, David C, Ho, Vincent T., MD, Hochberg, Ephraim, MD, McAfee, Steven L., MD, Takvorian, Ronald, MD, Antin, Joseph H., MD, Soiffer, Robert J., MD, Jacobsen, Eric, MD
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1083-8791
1523-6536
DOI:10.1016/j.bbmt.2013.12.088